?We are desperate for new therapies?: Experts discuss AML during the Sanford Burnham Prebys community lecture series

San Diego Biotechnology Network
San Diego Biotechnology Network
?We are desperate for new therapies?: Experts discuss AML during the Sanford Burnham Prebys community lecture series
Loading
/

Bill Veljovich had never been sick in his life. ?Not even joint pain,? shared the 80-year-old retired engineer at our recent Fleet Science Center discussion about acute myeloid leukemia (AML), a life-threatening type of blood cancer. He was joined by experts from Sanford Burnham Prebys and UC San Diego Health.
?